March 26, 2008 09:00 ET
PHT Launches SitePad™ Tablet to Clinical Research Industry With Worldwide Virtual Launch on March 28
Webinar Offers CEO Insights, Live Product Demo, Chance to Win a Samsung UMPC
BOSTON, MA--(Marketwire - March 26, 2008) - PHT Corporation, the market-leading provider of
electronic patient reported outcome (ePRO) solutions used in more than 345
clinical trials worldwide, will host an informative webinar to launch its
revolutionary SitePad™ Tablet on Friday, March 28, 2008 from 11am-12pm
(Eastern). Registration is online at: www.regonline.com/tablet.
PHT's SitePad™ Tablet is a breakthrough technology that will forever change
the quality of site-based ePRO data capture worldwide. The complimentary
virtual launch will feature an introduction by President and CEO Phil Lee
and an exclusive product demonstration by Sheila Rocchio, Vice President of
Marketing. Interactive questions will be entertained at the close of the
presentation, and one attendee will win a Samsung Q1 Ultra Mobile PC.
All are welcome to attend the virtual launch by registering at:
www.regonline.com/tablet.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome
(ePRO) solutions used in more than 345 clinical trials by 90
biopharmaceutical clients around the world. The company's proven LogPad®
and StudyPad® Systems deliver the voice of the patient -- directly and
without distortion -- with reliable and timely self-reported data. Patient
experiences captured firsthand by PHT's ePRO Product Suite have been used
successfully in at least nine NDA submissions, with five known approvals,
to date. To learn more about how study sponsors worldwide are using ePRO to
improve data quality, conduct smaller trials, and manage patient safety,
enrollment and compliance in real time, visit www.phtcorp.com.
PHT, LogPad and SitePad are among the registered trademarks and trademarks
of PHT Corporation.